Doesn't matter in that Takeda will sell Pulmonary off to a small biotech. Take it to the bank, Jack!
You don’t know plasma do you
Pulmonary Team will be gone. People negotiating away from that team as we speak.
Shire doesn't even manufacture one of the 2 therapies they sell and don't get paid on the other.
They used to throw that fractionation portion of plasma away. Literally tossed it out.
It will go to another Company who sells in that space.
Its you who doesn't know plasma or the history behind this therapy.
Pulmonary Team will be gone. People negotiating away from that team as we speak.
Shire doesn't even manufacture one of the 2 therapies they sell and don't get paid on the other.
They used to throw that fractionation portion of plasma away. Literally tossed it out.
It will go to another Company who sells in that space.
Its you who doesn't know plasma or the history behind this therapy.
Is this something you heard or are you speculating?
And you’re right. The fact that we don’t get paid on Aralast is really sketchy. Another way to screw the field. Thanks Brent and good riddance!
Shire has to sell so much of the Glassia which is manufactured by Kamada Therapeutics. That's why no pay on Aralast. Look at the competition, none of which are actively promoting A1. SPPs can do all the work.
it will be the easiest way to reduce sales force that's brings in little growth. Just not sure how long the agreement with Kamada is for????? Good luck.